GSK and Alphabet team up to find biolectronic cures

Google’s parent company Alphabet is teaming up with British drug company GlaxoSmithKline to invest in bioelectronics. The aim is to treat diseases by targeting the electronic signals that pass along the body’s nerves. Chris Nuttall discusses the prospects for this new branch of medicine with the FT’s Science editor Clive Cookson

Hosted on Acast. See acast.com/privacy for more information.

More from FT News in Focus

  1. 17:59Introducing: The Rachman ReviewMar 25, 2020
  2. 10:56Republican $1tn plan, Paul Tucker on damage limitsMar 20, 2020
  3. 07:56Rana Foroohar on the trillion dollar fightback, Biden sweepMar 18, 2020
  4. 09:04World on lockdown, markets melt, hospitals sufferMar 17, 2020
  5. 08:18Introducing the FT News Briefing: Fed cuts to zero, airport pinch, hand sanitiser saleMar 16, 2020
  6. 16:04Persecution of China's Uighur Muslims exposedMar 11, 2020
  7. 14:40Will coronavirus cause a global recession?Mar 09, 2020
  8. 13:52Secrets of the South PoleMar 04, 2020
  9. 13:52Is India becoming a Big Brother state?Mar 02, 2020
  10. 17:14Is Trump abusing his power over the judiciary?Feb 26, 2020